Operating profit before deduction of amortization: Barinthus Biotherapeutics plc (BRNS)
The growth of Barinthus Biotherapeutics (BRNS) depends on the efficacy of T-cell vaccines and stable capital. The EBITDA financial metric clearly demonstrates the impact of corporate news on cash flow, where 0.00 serves as the final level marker. Barinthus Biotherapeutics (BRNS) is implementing "green chemistry" to protect the environment while maintaining high authority within the scientific community through innovative methods of combating infections.
barinthusbio.com (BRNS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Barinthus Biotherapeutics|BRNS - Long-Term Debt to Capital|Current Liabilities to Capital Barinthus Bio|BRNS - Company Aggregate Debts|Debt to Book Capitalization Ratio Barinthus Biotherapeutics plc|BRNS - Company Long-Term Debts|Company Short-Term Debts Barinthus Biotherapeutics|Intermediate Coverage Ratio barinthusbio.com
- earnings and multiples data:
BRNS - Net Profit|Company Profit Forecast Barinthus Biotherapeutics|BRNS - Price to Earnings Ratio|Price to Future Earnings Ratio Barinthus Bio|BRNS - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Barinthus Biotherapeutics plc|BRNS - Operating profit EBITDA|Earnings per share for the trailing year Barinthus Biotherapeutics|BRNS - Net earnings per share for the last 12 months|Quarterly EPS earnings growth barinthusbio.com|BRNS - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Barinthus Biotherapeutics
- sales and revenue indicators:
Summary company analytics:Barinthus Biotherapeutics (BRNS)
Barinthus Biotherapeutics (BRNS) cost optimization through the outsourcing of clinical trials directly impacts operating cash flow. An analysis of current EBITDA allows for an assessment of the actual volume of operating income before depreciation and taxes, where the upward trend confirms effective capital management and growing market confidence in the issuer's fundamental stability.
Who Barinthus Biotherapeutics competes with
Operating income before deduction of amortization argenx.com (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax Corp (ABVX) - Operating profit before deduction of amortization|ADMA Corp (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics|Operating profit before deduction of amortization IMVT|Operating profit EBITDA kiniksa.com|Profit before payment of interest, taxes and amortization Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Operating profit before amortization|Operating profit EBITDA CLDX (celldex.com)|Aurinia Pharma (AUPH) - Profit before interest, taxes and amortization|BioCryst - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Pharvaris - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Bio) - Operating profit EBITDA|Operating profit EBITDA Tourmaline|Operating profit EBITDA PGEN|PHAR (pharming.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (nektar.com)|Upstream Bio (UPB) - Profit before interest, taxes and amortization|ZBIO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Immunome Bio|GOSS: Operating profit EBITDA|KALV: Company profit before taxes, interest and amortization|SEPN (septerna.com) - Operating profit EBITDA|Pieris Pharmaceuticals, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Savara Inc. (SVRA)|Operating profit EBITDA Rigel Corp (RIGL)|Profit before payment of interest, taxes and amortization AnaptysBio Inc ANAB|astriatx.com (ATXS) - Profit before interest, taxes and amortization|enGene Bio - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RAPT|JBIO: Operating profit EBITDA|Aclaris - Income before deduction of interest, taxes and amortization|KYTX (Kyverna Therapeutics, Inc) - Operating profit EBITDA|TLSA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CABA (Cabaletta Bio)|VTYX - Profit before interest, taxes and amortization|Operating profit EBITDA THTX (Theratechnologies, Inc)|Company profit before taxes, interest and amortization AVTX (Avalo Therapeutics Inc.)|ELDN: Operating profit before deduction of amortization|AGEN - Operating profit EBITDA|Climb Bio Inc. (CLYM) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZURA (Zura Bio)|Operating profit before deduction of amortization ATYR|ADAG: Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMA|Operating income before deduction of amortization Shattuck Therapeutics|Operating profit EBITDA EQ (Equillium Inc)|Company profit before taxes, interest and amortization CNTB (Connect Pharma)|IMUX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization atarabio.com ATRA|IFRX: Operating profit EBITDA|XFOR (X4 Pharmaceuticals, Inc) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization adicetbio.com|CELU: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization INmune Bio Corporation (INMB)|Operating profit EBITDA Kezar Life Sciences Inc (KZR)|Operating profit EBITDA SABS (SAB Biotherapeutics)|Operating profit EBITDA akaritx.com AKTX|Enlivex Therapeutics Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GOVX (GeoVax Labs Inc) - Operating profit before deduction of amortization|Operating profit before deduction of amortization Edesa|IBIO (iBio, Inc.) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit before deduction of amortization Bolt Biotherapeutics, Inc. BOLT|Operating profit EBITDA HCWB (hcwbiologics.com)|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech, Inc. - Operating profit EBITDA|ADTX (Aditxt Inc.) - Operating profit before amortization|GRI: Operating profit EBITDA|Operating profit before deduction of amortization XORTX Therapeutics|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization indaptusrx.com (INDP)|Operating profit before deduction of amortization Scinai Immunotherapeutics SCNI|Operating profit EBITDA CALI (CalciMedica Inc)|AFMD: Operating profit before amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization hookipapharma.com|IGMS: Operating profit EBITDA|ITOS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical Corp) - Operating profit EBITDA|TCBP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc (THRD)
